Invention Grant
- Patent Title: Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
-
Application No.: US16634986Application Date: 2018-07-30
-
Publication No.: US12201612B2Publication Date: 2025-01-21
- Inventor: Ricardo Carl Elciario Dolmetsch , Fabrizio Gasparini , Baltazar Gomez-Mancilla , Donald Johns
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agency: MILLEN, WHITE, ZELANO & BRANIGAN, P.C.
- Agent Ryan R. Pool
- International Application: PCT/IB2018/055665 WO 20180730
- International Announcement: WO2019/025932 WO 20190207
- Main IPC: A61K31/403
- IPC: A61K31/403 ; A61K45/06 ; A61P25/32
Abstract:
The invention relates to the use of mavoglurant, or a pharmaceutically acceptable salt thereof: in the reduction of alcohol use by an alcohol use disorder patient; in preventing relapse into alcohol use by an alcohol use disorder patient; in the promotion of alcohol abstinence by an alcohol use disorder patient; in the treatment of the symptoms of depression or anxiety associated with alcohol use disorder.
Public/Granted literature
- US20200237721A1 USE OF MAVOGLURANT IN THE REDUCTION OF ALCOHOL USE OR IN PREVENTING RELAPSE INTO ALCOHOL USE Public/Granted day:2020-07-30
Information query
